[1]
Carriero, M. 2022. Erythrodermic psoriasis and palmoplantar hyperkeratosis successfully treated with secukinumab: a case report. Drug Target Insights. 16, 1 (Mar. 2022), 1–5. DOI:https://doi.org/10.33393/dti.2022.2355.